Author Correction: Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes.
Saved in:
| Title: | Author Correction: Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes. |
|---|---|
| Authors: | Diamanti K; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden., Visvanathar R; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden., Pereira MJ; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden., Cavalli M; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Pan G; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Kumar C; Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Karolinska Institute/AstraZeneca Integrated CardioMetabolic Centre (KI/AZ ICMC), Department of Medicine, Novum, Huddinge, Sweden., Skrtic S; Pharmaceutical Technology & Development, AstraZeneca AB, Gothenburg, Sweden.; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Risérus U; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden., Eriksson JW; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden., Kullberg J; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.; Antaros Medical AB, Mölndal, Sweden., Komorowski J; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.; Institute of Computer Science, PAN, Warsaw, Poland., Wadelius C; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Ahlström H; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden. hakan.ahlstrom@radiol.uu.se.; Antaros Medical AB, Mölndal, Sweden. hakan.ahlstrom@radiol.uu.se. |
| Source: | Scientific reports [Sci Rep] 2024 Nov 28; Vol. 14 (1), pp. 29632. Date of Electronic Publication: 2024 Nov 28. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39609490 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Integration of whole-body [<superscript>18</superscript>F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Diamanti+K%22">Diamanti K</searchLink>; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Visvanathar+R%22">Visvanathar R</searchLink>; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Pereira+MJ%22">Pereira MJ</searchLink>; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Cavalli+M%22">Cavalli M</searchLink>; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Pan+G%22">Pan G</searchLink>; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Kumar+C%22">Kumar C</searchLink>; Translational Science & Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Karolinska Institute/AstraZeneca Integrated CardioMetabolic Centre (KI/AZ ICMC), Department of Medicine, Novum, Huddinge, Sweden.<br /><searchLink fieldCode="AU" term="%22Skrtic+S%22">Skrtic S</searchLink>; Pharmaceutical Technology & Development, AstraZeneca AB, Gothenburg, Sweden.; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Risérus+U%22">Risérus U</searchLink>; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Eriksson+JW%22">Eriksson JW</searchLink>; Department of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Kullberg+J%22">Kullberg J</searchLink>; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden.; Antaros Medical AB, Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Komorowski+J%22">Komorowski J</searchLink>; Science for Life Laboratory, Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden.; Institute of Computer Science, PAN, Warsaw, Poland.<br /><searchLink fieldCode="AU" term="%22Wadelius+C%22">Wadelius C</searchLink>; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Ahlström+H%22">Ahlström H</searchLink>; Department of Surgical Sciences, Section of Radiology, Uppsala University, Uppsala, Sweden. hakan.ahlstrom@radiol.uu.se.; Antaros Medical AB, Mölndal, Sweden. hakan.ahlstrom@radiol.uu.se. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2024 Nov 28; Vol. 14 (1), pp. 29632. <i>Date of Electronic Publication: </i>2024 Nov 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39609490 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-024-78537-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 29632 Titles: – TitleFull: Author Correction: Integration of whole-body [18F]FDG PET/MRI with non-targeted metabolomics can provide new insights on tissue-specific insulin resistance in type 2 diabetes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Diamanti K – PersonEntity: Name: NameFull: Visvanathar R – PersonEntity: Name: NameFull: Pereira MJ – PersonEntity: Name: NameFull: Cavalli M – PersonEntity: Name: NameFull: Pan G – PersonEntity: Name: NameFull: Kumar C – PersonEntity: Name: NameFull: Skrtic S – PersonEntity: Name: NameFull: Risérus U – PersonEntity: Name: NameFull: Eriksson JW – PersonEntity: Name: NameFull: Kullberg J – PersonEntity: Name: NameFull: Komorowski J – PersonEntity: Name: NameFull: Wadelius C – PersonEntity: Name: NameFull: Ahlström H IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 11 Text: 2024 Nov 28 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |